134 related articles for article (PubMed ID: 8297480)
1. Increased expression of stromelysin-3 in basal cell carcinomas.
Majmudar G; Nelson BR; Jensen TC; Voorhees JJ; Johnson TM
Mol Carcinog; 1994 Jan; 9(1):17-23. PubMed ID: 8297480
[TBL] [Abstract][Full Text] [Related]
2. Expression of stromelysin 3 in the stromal elements of human basal cell carcinoma.
Wagner SN; Ruhri C; Kunth K; Holecek BU; Goos M; Höfler H; Atkinson MJ
Diagn Mol Pathol; 1992 Sep; 1(3):200-5. PubMed ID: 1342967
[TBL] [Abstract][Full Text] [Related]
3. Differential patterns of stromelysin-2 (MMP-10) and MT1-MMP (MMP-14) expression in epithelial skin cancers.
Kerkelä E; Ala-aho R; Lohi J; Grénman R; M-Kähäri V; Saarialho-Kere U
Br J Cancer; 2001 Mar; 84(5):659-69. PubMed ID: 11237387
[TBL] [Abstract][Full Text] [Related]
4. A switch from stromal to tumor cell expression of stromelysin-1 mRNA associated with the conversion of squamous to spindle carcinomas during mouse skin tumor progression.
Wright JH; McDonnell S; Portella G; Bowden GT; Balmain A; Matrisian LM
Mol Carcinog; 1994 Aug; 10(4):207-15. PubMed ID: 8068181
[TBL] [Abstract][Full Text] [Related]
5. Human collagenase-3 is expressed in malignant squamous epithelium of the skin.
Airola K; Johansson N; Kariniemi AL; Kähäri VM; Saarialho-Kere UK
J Invest Dermatol; 1997 Aug; 109(2):225-31. PubMed ID: 9242512
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase-19 is expressed by proliferating epithelium but disappears with neoplastic dedifferentiation.
Impola U; Toriseva M; Suomela S; Jeskanen L; Hieta N; Jahkola T; Grenman R; Kähäri VM; Saarialho-Kere U
Int J Cancer; 2003 Mar; 103(6):709-16. PubMed ID: 12516088
[TBL] [Abstract][Full Text] [Related]
7. Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization.
Pyke C; Ralfkiaer E; Huhtala P; Hurskainen T; Danø K; Tryggvason K
Cancer Res; 1992 Mar; 52(5):1336-41. PubMed ID: 1310643
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinases in keratinocyte carcinomas.
Riihilä P; Nissinen L; Kähäri VM
Exp Dermatol; 2021 Jan; 30(1):50-61. PubMed ID: 32869366
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of tissue inhibitor of metalloproteinases-2 by cutaneous squamous and basal cell carcinomas.
Wagner SN; Ockenfels HM; Wagner C; Soyer HP; Goos M
J Invest Dermatol; 1996 Feb; 106(2):321-6. PubMed ID: 8601735
[TBL] [Abstract][Full Text] [Related]
10. Stromelysin-3 (ST-3) mRNA expression in colorectal carcinomas. Localization and clinicopathologic correlations.
Thewes M; Pohlmann G; Atkinson M; Mueller J; Pütz B; Höfler H
Diagn Mol Pathol; 1996 Dec; 5(4):284-90. PubMed ID: 8955621
[TBL] [Abstract][Full Text] [Related]
11. Breast-cancer-associated stromelysin-3 gene is expressed in basal cell carcinoma and during cutaneous wound healing.
Wolf C; Chenard MP; Durand de Grossouvre P; Bellocq JP; Chambon P; Basset P
J Invest Dermatol; 1992 Dec; 99(6):870-2. PubMed ID: 1469302
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of matrix metalloproteinase-3 (stromelysin-1) in cultured fibroblasts and basal cell carcinomas of nevoid basal cell carcinoma syndrome.
Majmudar G; Nelson BR; Jensen TC; Johnson TM
Mol Carcinog; 1994 Sep; 11(1):29-33. PubMed ID: 7916987
[TBL] [Abstract][Full Text] [Related]
13. Stromelysin-3 (ST-3): immunohistochemical characterization of the matrix metalloproteinase (MMP)-11 in benign and malignant skin tumours and other skin disorders.
Thewes M; Worret WI; Engst R; Ring J
Clin Exp Dermatol; 1999 Mar; 24(2):122-6. PubMed ID: 10233668
[TBL] [Abstract][Full Text] [Related]
14. Expression of matrix metalloproteinase-1, -2 and -3 in squamous cell carcinoma and actinic keratosis.
Tsukifuji R; Tagawa K; Hatamochi A; Shinkai H
Br J Cancer; 1999 Jun; 80(7):1087-91. PubMed ID: 10362121
[TBL] [Abstract][Full Text] [Related]
15. Different expression patterns of calpain isozymes 1 and 2 (CAPN1 and 2) in squamous cell carcinomas (SCC) and basal cell carcinomas (BCC) of human skin.
Reichrath J; Welter C; Mitschele T; Classen U; Meineke V; Tilgen W; Seifert M
J Pathol; 2003 Apr; 199(4):509-16. PubMed ID: 12635142
[TBL] [Abstract][Full Text] [Related]
16. Gene expression of matrix metalloproteinase-1 (interstitial collagenase) and matrix metalloproteinase-3 (stromelysin-1) in basal cell carcinoma by in situ hybridization using chondroitin ABC lyase.
Tsukifuji R; Sakai Y; Hatamochi A; Shinkai H
Histochem J; 1997 May; 29(5):401-7. PubMed ID: 9184854
[TBL] [Abstract][Full Text] [Related]
17. Expression of basement membrane antigens and matrix metalloproteinases 2 and 9 in cutaneous basal and squamous cell carcinomas.
Dumas V; Kanitakis J; Charvat S; Euvrard S; Faure M; Claudy A
Anticancer Res; 1999; 19(4B):2929-38. PubMed ID: 10652575
[TBL] [Abstract][Full Text] [Related]
18. Expression of human macrophage metalloelastase (MMP-12) by tumor cells in skin cancer.
Kerkelä E; Ala-Aho R; Jeskanen L; Rechardt O; Grénman R; Shapiro SD; Kähäri VM; Saarialho-Kere U
J Invest Dermatol; 2000 Jun; 114(6):1113-9. PubMed ID: 10844553
[TBL] [Abstract][Full Text] [Related]
19. Localization by in situ hybridization of mRNAs encoding stromelysin 3 and tissue inhibitors of metallo-proteinases TIMP-1 and TIMP-2 in human head and neck carcinomas.
Polette M; Clavel C; Birembaut P; De Clerck YA
Pathol Res Pract; 1993 Nov; 189(9):1052-7. PubMed ID: 8302724
[TBL] [Abstract][Full Text] [Related]
20. Increased stromelysin 3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinomas.
Muller D; Wolf C; Abecassis J; Millon R; Engelmann A; Bronner G; Rouyer N; Rio MC; Eber M; Methlin G
Cancer Res; 1993 Jan; 53(1):165-9. PubMed ID: 7677979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
